Search research articles
Contact Us
Filters
Showing results (71-80 of 78) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 78 results.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
January 5, 2002
Preclinical pharmacokinetics of SB-203580, a potent inhibitor of p38 mitogen-activated protein kinase
K W Ward, J W Prokscht, L M Azzaranot, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 1, 1997
Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo
B J Votta, M A Levy, A Badger, et al.
Clinical Epigenetics
|
January 7, 2021
DNA methylation epi-signature is associated with two molecularly and phenotypically distinct clinical subtypes of Phelan-McDermid syndrome
L C Schenkel, E Aref-Eshghi, K Rooney, et al.
Journal of Medicinal Chemistry
|
October 10, 1998
Structure-based design of cathepsin K inhibitors containing a benzyloxy-substituted benzoyl peptidomimetic
S K Thompson, W W Smith, B Zhao, et al.
Journal of Medicinal Chemistry
|
September 11, 1998
Conformationally constrained 1,3-diamino ketones: a series of potent inhibitors of the cysteine protease cathepsin K
R W Marquis, D S Yamashita, Y Ru, et al.
Bioorganic & Medicinal Chemistry
|
June 3, 1999
Potent dipeptidylketone inhibitors of the cysteine protease cathepsin K
R W Marquis, Y Ru, D S Yamashita, et al.
The Journal of Biological Chemistry
|
May 24, 2000
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality
D Lee, S A Long, J L Adams, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 7, 1998
Design of potent and selective human cathepsin K inhibitors that span the active site
S K Thompson, S M Halbert, M J Bossard, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 78) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 78 results.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
January 5, 2002
Preclinical pharmacokinetics of SB-203580, a potent inhibitor of p38 mitogen-activated protein kinase
K W Ward, J W Prokscht, L M Azzaranot, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 1, 1997
Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo
B J Votta, M A Levy, A Badger, et al.
Clinical Epigenetics
|
January 7, 2021
DNA methylation epi-signature is associated with two molecularly and phenotypically distinct clinical subtypes of Phelan-McDermid syndrome
L C Schenkel, E Aref-Eshghi, K Rooney, et al.
Journal of Medicinal Chemistry
|
October 10, 1998
Structure-based design of cathepsin K inhibitors containing a benzyloxy-substituted benzoyl peptidomimetic
S K Thompson, W W Smith, B Zhao, et al.
Journal of Medicinal Chemistry
|
September 11, 1998
Conformationally constrained 1,3-diamino ketones: a series of potent inhibitors of the cysteine protease cathepsin K
R W Marquis, D S Yamashita, Y Ru, et al.
Bioorganic & Medicinal Chemistry
|
June 3, 1999
Potent dipeptidylketone inhibitors of the cysteine protease cathepsin K
R W Marquis, Y Ru, D S Yamashita, et al.
The Journal of Biological Chemistry
|
May 24, 2000
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality
D Lee, S A Long, J L Adams, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 7, 1998
Design of potent and selective human cathepsin K inhibitors that span the active site
S K Thompson, S M Halbert, M J Bossard, et al.
Page
of 8